Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Radius to launch Phase I vasomotor trial in women
Radius plans to begin a Phase I clinical trial of RAD1901 in healthy postmenopausal women in the Netherlands in March 2008. The study will evaluate the safety, tolerability,
Radius plans to begin a Phase I clinical trial of RAD1901 in healthy postmenopausal women in the Netherlands in March 2008. The study will evaluate the safety, tolerability,
Under the terms of the agreement, Harvard has granted Millennium a license to certain invention from the laboratory of Wade Harper and the two institutions will jointly advance
The study results indicated that among the animals treated with the APA-01 and atorvastatin combination, total cholesterol levels fell by up to an additional 12% compared to those
The underwriters have an option to purchase up to an additional 750,000 shares to cover over-allotments, if any. The offering is expected to close on February 6, 2008,
The company has developed two unique supplement lines and is developing treatments for diseases. The new Cavit facility is significantly larger than the company’s previous space and accommodates
This latest Phase II trial is an international, multi-center, double-blind and placebo-controlled study of SA4503 in patients with stroke with a planned enrollment of approximately 60 patients. The
The investment syndicate includes new investors Goldman Sachs and Invesco Perpetual, as well as existing investors, including Imperial Innovations and Lansdowne Partners. This second investment round has increased
The transaction involved a total capital investment of $74.6 million, in cash paid to Guangzhou Pharmaceuticals (GP Corp.) in exchange for a 50% ownership interest in GP Corp.
The new CGMS iPro Recorder is smaller, lighter in weight and less time consuming to use than previous CGMS recorders. Physicians can now gain added clinical insights from
The financing was led by individual investors including Carl Lombardi, former CEO of SpaceLabs Medical and Sam Naficy, medical director of Naficy Plastic Surgery & Rejuvenation Center. The